Get started
Aura Biosciences, Inc.Aura Biosciences, Inc.Aura Biosciences, Inc.

Aura Biosciences, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

AURA chart

Upcoming earnings

Next report date
Report period
Q1 2024
EPS estimate
−0.49USD
Revenue estimate
—

Key stats

Market capitalization
‪357.63 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.93USD
Net income (FY)
‪−76.41 M‬USD
Revenue (FY)
—
Shares float
‪39.71 M‬
Beta (1Y)
3.57

About Aura Biosciences, Inc.

Sector
Health Technology
Industry
Biotechnology
CEO
Elisabet de los Pinos
Website
aurabiosciences.com
Headquarters
Boston
Employees (FY)
89
Founded
2007
FIGI
BBG00226DGM5
Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of AURA is 7.54 USD — it has increased by 4.43% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aura Biosciences, Inc. stocks are traded under the ticker AURA.
Aura Biosciences, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
AURA stock is 9.71% volatile and has beta coefficient of 3.57. Check out the list of the most volatile stocks — is Aura Biosciences, Inc. there?
AURA earnings for the last quarter are −0.48 USD per share, whereas the estimation was −0.52 USD resulting in a 7.83% surprise. The estimated earnings for the next quarter are −0.42 USD per share. See more details about Aura Biosciences, Inc. earnings.
Yes, you can track Aura Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
AURA stock has risen by 4.14% compared to the previous week, the month change is a 2.08% fall, over the last year Aura Biosciences, Inc. has showed a 17.69% decrease.
AURA net income for the last quarter is ‪−22.13 M‬ USD, while the quarter before that showed ‪−18.51 M‬ USD of net income which accounts for −19.55% change. Track more Aura Biosciences, Inc. financial stats to get the full picture.
Today Aura Biosciences, Inc. has the market capitalization of ‪357.42 M‬, it has decreased by 2.34% over the last week.
No, AURA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AURA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aura Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
AURA reached its all-time high on Nov 16, 2021 with the price of 26.16 USD, and its all-time low was 5.99 USD and was reached on Nov 7, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 29, 2024, the company has 89.00 employees. See our rating of the largest employees — is Aura Biosciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aura Biosciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aura Biosciences, Inc. stock shows the strong sell signal. See more of Aura Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Aura Biosciences, Inc. future price: according to them, AURA price has a max estimate of 21.00 USD and a min estimate of 19.00 USD. Read a more detailed Aura Biosciences, Inc. forecast: see what analysts think of Aura Biosciences, Inc. and suggest that you do with its stocks.